The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens

Journal of Investigative Dermatology

Volumn 107, Issue 3, 1996, Pages 392-397

  Berger, Carole L ^a   Wang, Nanci ^a   Christensen, Inger ^a   Longley, Jack ^a   Heald, Peter ^a   Edelson, Richard L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytotoxic T cells; Immunotherapy; T cell leukemia; Tumor associated peptides

Indexed keywords

CD8 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CASE REPORT; HUMAN; IMMUNOTHERAPY; LYMPHOCYTE; PRIORITY JOURNAL; T CELL LYMPHOMA;

EID: 0029793149     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12363378     Document Type: Article

References (27)

1. Bagot M, Wechsler J, Lecs MC, Revuz J, Farcet JP, Gaulard P: Intra-epidermal localization of the clone in cutaneous T-cell lymphoma. J Am Acad Dermatol 27:589-593, 1992
2. Bevan MJ: High determinant density may explain the phenomenon of alloreactivity. Immunol Today 5:128-130, 1984
3. Boyum A: Isolation of leukocytes from human blood. Scan J Clin Lab Invest 21(suppl 97):31-50, 1968
4. Charley M, McCoy JP, Deng J-S, Jegasothy B: Anti-V region antibodies as "almost clonotypic" reagents for the study of cutaneous T cell lymphomas and leukemias. J Invest Dermatol 95:614-617, 1990
5. Dalloul A, LaRoche L, Bagot M, Mossalay D, Fourcade C, Thacker D, Hogge D, Merle-Beral H, Debre P, Schmitt C: Interleukin-7 is a growth factor for Sezary cells. J Clin Invest 90:1054-1060, 1992
6. Edelson R: Cutaneous T cell lymphoma (mycosis fungoides, Sezary syndrome and other variants). J Am Acad Dermatol 2:89-106, 1980
7. Edelson R, Berger C, Raafat J, Warburton D: Karyotype studies of cutaneous T-cell lymphoma: evidence for clonal origin. J Invest Dermatol 73:548-550, 1979
8. Edelson RL, Berger CL, Gasparro F, Jegasothy B, Heald P, Wintroub B, Vonderheid E, Knobler R, Wolff K, Plewig G, McKiernan G, Christiansen I, Oster M, Honigsmann H, Wilford H, Kokoschka E, Rehle T, Perez M, Stingl G, LaRoche L: Treatment of cutaneous T cell lymphoma by extracorporeal photochemotherapy: preliminary results. N Engl J Med 316:297-303, 1987
9. Falk CS, Steinle A, Schendel DJ: Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analagous to allospecific natural killer cells. J Exp Med 182:1005-1018, 1995
10. Heald P, Rook A, Perez M, Wintroub B, Knobler R, Jegasothy B, Gasparro F, Berger C, Edelson R: Treatment of erythrodermic cutaneous T cell lymphoma with extracorporeal photochemotherapy. J Am Acad Dermatol 27:427-433, 1992
11. Hill AB, Lee SP, Haurum JS: Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr Virus (EBV) nuclear antigens fail to lyse the EBV-transformed B lymphoblastoid cell lines against which they were raised. J Exp Med 181:2221-2228, 1995
12. Kannagi M, Matsushita S, Harada, S: Expression of the target antigen for cytotoxic T lymphocytes on adult T-cell leukemia cells. Int J Cancer 54:582-588, 1993
13. Kelly A, Powis SH, Kerr LA, Mockridge I, Elliott T, Bastin J, Uchanska-Ziegler A, Townsend A: Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex. Nature 355:641-644, 1992
14. Kung PC, Berger CL, Goldstein G, LoGerfo P, Edelson RL: Cutaneous T cell lymphoma: characterization by monoclonal antibodies. Blood 57:261-266, 1981
15. Lynch DH, Miller RE: Interleukin 7 promotes long-term in vitro growth of anti-tumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo. J Exp Med 179:31-42, 1994
16. Massocchi A, Belli F, Mascheroni L, Vegetti C, Parmiani G, Anichini A: Frequency of cytotoxic T lymphocyte precursors (CTLp) interacting with autologous tumor via the T-cell receptor: limiting dilution analysis of specific CTLp in peripheral blood and tumor-invaded lymph nodes of melanoma patients. Int J Cancer 58:330-339, 1994
17. Nickoloff BJ, Griffiths CEM: Intraepidermal but not dermal T lymphocytes are positive for a cell-cycle associated antigen (Ki-67) in mycosis fungoides. Am J Pathol 136:261-265, 1990
18. Perez M, Edelson R, LaRoche L, Berger CL: Specific suppression of anti-allograft immunity by vaccination with syngeneic photoinactivated splenocytes. J Invest Dermatol 92:669-676, 1989
19. Picker LJ, Michie SA, Rott LS, Butcher EC: A unique phenotype of skin-associated lymphocytes in humans: preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. Am J Pathol 136:1053-1068, 1990
20. Picker LJ, Kishimoto TK, Smith CW, Warnock RA, Butcher EC: ELAM-1 is an adhesion molecule for skin-homing T cells. Nature 349:796-799, 1991
21. Rotzschke O, Falk K: Naturally-occurring peptide antigens derived from the MHC class I restricted processing pathway. Immunol Today 12:447-455, 1991
22. Terhune MH, Cooper KD: Gene rearrangements and T-cell lymphomas. Arch Dermatol 129:1484-1490, 1993
23. Townsend A, Ohlen C, Rogers M, Edwards J, Mukherjee S, Bastin J: Source of unique tumor antigens. Nature 371:662, 1994
24. Vowels BR, Cassin M, Boufal MH, Walsh LJ, Rook AH: Extracorporeal photochemotherapy induces the production of tumor necrosis factor-alpha by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis. J Invest Dermatol 98:686-692, 1992
25. + T cells that lack CD11b, CD16, CD56, CD57, and human hanukah factor mRNA. Am J Pathol 138:1545-1552, 1991
26. Young JW, Inaba K: Dendritic cells as adjuvants for class I major histocompatability complex-restricted antitumor immunity. J Exp Med 183:7-11, 1996
27. Zychlinsky A, Zheng L, Liu C, Young J: Cytolytic lymphocytes induce both apoptosis and necrosis in target cells. J Immunol 146:393-400, 1991